Application 021430
- Type
- NDA
- Sponsor
- CELGENE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | THALOMID | THALIDOMIDE | CAPSULE; ORAL | 50MG | No | No |
| 002 | THALOMID | THALIDOMIDE | CAPSULE; ORAL | 100MG | No | No |
| 003 | THALOMID | THALIDOMIDE | CAPSULE; ORAL | 200MG | No | No |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.